Back to Search
ANDREW TERSHAKOVEC, MD
MD
Pediatrics Physician
NPI: 1306119649Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
MD038079E(PA)
Research & Publications (20)
Body composition and metabolic factors in obese children and adolescents.
PMID 12532149·Int J Obes Relat Metab Disord·2003
8-other
Persistent hypercholesterolemia is associated with the development of obesity among girls: the Bogalusa Heart Study.
PMID 12324284·Am J Clin Nutr·2002
8-other
Age, sex, ethnicity, body composition, and resting energy expenditure of obese African American and white children and adolescents.
PMID 11976160·Am J Clin Nutr·2002
8-other
Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
PMID 19589894·Rheumatology (Oxford)·2009
4-observational
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.
PMID 19125857·J Clin Hypertens (Greenwich)·2009
6-review
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
PMID 19508464·Diabetes Obes Metab·2009
4-observational
Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
PMID 19660610·Am J Cardiol·2009
2-rct
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
PMID 19166691·Am J Cardiol·2009
8-other
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
PMID 19539078·Am J Cardiol·2009
4-observational
Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
PMID 19026303·Am J Cardiol·2008
4-observational
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
PMID 18328120·Curr Med Res Opin·2008
4-observational
Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
PMID 19026302·Am J Cardiol·2008
4-observational
Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
PMID 18514551·Osteoarthritis Cartilage·2008
4-observational
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.
PMID 18070995·Diabetes Care·2008
8-other
Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain.
PMID 18317199·Spine (Phila Pa 1976)·2008
2-rct
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
PMID 18420099·J Am Coll Cardiol·2008
4-observational
Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia.
PMID 18782465·Curr Med Res Opin·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1949 COUNTRY CLUB DR
HUNTINGDON VALLEY, PA 19006 - Phone
- (215) 830-1221
Quick Facts
- NPI
- 1306119649
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile